Galafold — Blue Cross Blue Shield of Montana
Fabry disease
Initial criteria
- Quantity limit for the Target Agent(s) will be approved when ONE of the following is met:
- 1. The requested quantity (dose) does NOT exceed the program quantity limit OR
- 2. The requested quantity (dose) exceeds the program quantity limit AND ONE of the following:
- A. BOTH of the following:
- 1. The requested agent does NOT have a maximum FDA labeled dose for the requested indication AND
- 2. There is support for therapy with a higher dose for the requested indication OR
- B. BOTH of the following:
- 1. The requested quantity (dose) does NOT exceed the maximum FDA labeled dose for the requested indication AND
- 2. There is support for why the requested quantity (dose) cannot be achieved with a lower quantity of a higher strength that does NOT exceed the program quantity limit
Approval duration
6–12 months